<DOC>
	<DOCNO>NCT00168220</DOCNO>
	<brief_summary>A case-control study look hypersensitive tolerant individual match HLA genetic predisposition , consider predictor drug hypersensitivity.The study aim identify immunological factor increase risk drug reaction HIV positive individual .</brief_summary>
	<brief_title>Predictors Drug Hypersensitivity HIV Infected Subjects</brief_title>
	<detailed_description>1 . To determine case control study clinical parameter associate drug HSR abacavir , nevirapine efavirenz HIV infect subject . 2 . To measure functional numerical difference DC population responses TLR ligands patient HSR tolerant subject share genetic marker susceptibility HSR . 3 . Identify role different DC population development abacavir reaction mix depletion study sensitize subject vitro assay abacavir hypersensitivity . 4 . To measure T cell parameter include T cell viability culture , expression fa fasL blood mononuclear cell HIV infect control HSR patient . 5 . To measure blood T cell population include drug reactive T cell T regulatory cell tolerant reactive subject genetic susceptibility Abacavir Nevirapine HSR .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Drug Hypersensitivity</mesh_term>
	<criteria>HIV infect patient treatment drug Efavirenz , Nevirapine , Abacavir . Age 18 Cases hypersensitivity reaction , control reaction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Treatment Experienced</keyword>
	<keyword>HIV</keyword>
</DOC>